Vibrational Spectroscopy for Pathology from Biochemical Analysis to Diagnostic Tool by Lyng, Fiona et al.
Technological University Dublin 
ARROW@TU Dublin 
Articles Radiation and Environmental Science Centre 
2007-01-01 
Vibrational Spectroscopy for Pathology from Biochemical 
Analysis to Diagnostic Tool 
Fiona Lyng 
Technological University Dublin, Fiona.lyng@tudublin.ie 
Eoghan O'Faolain 
Technological University Dublin 
J. Conroy 
Trinity College Dublin 
Aidan Meade 
Technological University Dublin, aidan.meade@tudublin.ie 
Peter Knief 
Technological University Dublin, peter.knief@tudublin.ie 
See next page for additional authors 
Follow this and additional works at: https://arrow.tudublin.ie/radart 
 Part of the Radiology Commons 
Recommended Citation 
Lyng, F. et al. (2007) Vibrational Spectroscopy for Pathology from Biochemical Analysis to Diagnostic 
Tool. Experimental and Molecular Pathology, Vol.82, no.2, pp.121-129. doi:10.1016/j.yexmp.2007.01.001 
This Article is brought to you for free and open access by 
the Radiation and Environmental Science Centre at 
ARROW@TU Dublin. It has been accepted for inclusion in 
Articles by an authorized administrator of ARROW@TU 
Dublin. For more information, please contact 
yvonne.desmond@tudublin.ie, arrow.admin@tudublin.ie, 
brian.widdis@tudublin.ie. 
This work is licensed under a Creative Commons 
Attribution-Noncommercial-Share Alike 3.0 License 
Authors 
Fiona Lyng, Eoghan O'Faolain, J. Conroy, Aidan Meade, Peter Knief, Brendan Duffy, M. Hunter, J. Byrne, P. 
Kelehan, and Hugh Byrne 
This article is available at ARROW@TU Dublin: https://arrow.tudublin.ie/radart/28 
 1 
Vibrational Spectroscopy for Cervical Cancer Pathology, from biochemical analysis to 
diagnostic tool 
 
F.M. Lyng1, E. Ó Faoláin2, J. Conroy3, A. Meade2, P. Knief2, B. Duffy2, M.B. Hunter4, J.M. 
Byrne4, P. Kelehan5 and H.J. Byrne2  
 
1Radiation and Environmental Science Centre, Focas Institute, Dublin Institute of Technology, 
Kevin St, Dublin 8, IRELAND 
2Focas Institute, Dublin Institute of Technology, Kevin St, Dublin 8, IRELAND 
3Department of Clinical Medicine, Trinity College Dublin, Dublin 2, IRELAND 
4Department of Histology, National Maternity Hospital, Holles St, Dublin 2, IRELAND 
5Department of Pathology and Laboratory Medicine, National Maternity Hospital, Holles St, 
Dublin 2, IRELAND 
 
Address for correspondence: 
Dr. Fiona M. Lyng 
Radiation and Environmental Science Centre 
Focas Institute 
Dublin Institute of Technology 
Kevin St, Dublin 8 
IRELAND 
Phone +35314027972 fax +35314027904 
Email: fiona.lyng@dit.ie  
* Manuscript
 2 
Abstract 
Cervical cancer is the second most common cancer in women worldwide with 80% of cases 
arising in the developing world.   The mortality associated with cervical cancer can be reduced if 
this disease is detected at the early stages of development or at the pre-malignant state (cervical 
intra-epithelial neoplasia, CIN).  The aim of this study was to investigate the potential of Raman 
spectroscopy as a diagnostic tool to detect biochemical changes accompanying cervical cancer 
progression.  Raman spectra were acquired from proteins, nucleic acids, lipids and carbohydrates 
in order to gain an insight into the biochemical composition of cells and tissues.  Spectra were 
also obtained from histological samples of normal, CIN and invasive carcinoma tissue from 40 
patients.  Multivariate analysis of the spectra was carried out to develop a classification model to 
discriminate normal from abnormal tissue.  The results show that Raman spectroscopy displays a 
high sensitivity to biochemical changes in tissue during disease progression resulting in an 
exceptional prediction accuracy when discriminating between normal cervical tissue, invasive 
carcinoma and cervical intra-epithelial neoplasia (CIN).   Raman spectroscopy shows enormous 
clinical potential as a rapid non invasive diagnostic tool for cervical and other cancers. 
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Introduction 
Cervical cancer is the second most common cancer among women worldwide and generally is 
more common in developing countries.  However, substantial decreases in cervical cancer 
mortality have been observed in Western countries and some developing countries with well 
developed screening programmes (Parkin et al 2005). A Pap smear is used to screen for CIN and 
cervical cancer in the general female population.  Cervical cytology can have a high specificity 
of 95-98% but a sensitivity of lower than 50% (Nanda et al 2000).  Other methods such as 
automated cytology and human papilloma virus (HPV) testing (Willis et al 2005, Bolger et al 
2006, Koliopoulos et al 2006) have been introduced to reduce the false negative rates.  An 
abnormal Pap smear is followed by colposcopic examination, biopsy and histological 
confirmation of the clinical diagnosis.  This involves the visual examination of histological 
sections.  The grading characteristics are quite subjective and pre-malignancy may not be 
visually perceptible at all.   
Optical technologies such as fluorescence spectroscopy (Chang et al 2005), polarised light 
scattering spectroscopy (Gurjar et al 2001), optical coherence tomography (Escobar et al 2004, 
Zuluaga et al 2005) and confocal reflectance microscopy (Carlson et al 2005) have emerged in 
recent years as promising tools for diagnosis of cervical and other cancers.  The potential of 
vibrational spectroscopy for cervical cancer diagnosis has also been recognised. A number of 
studies have shown that Fourier Transform Infra Red (FTIR) spectroscopy (Wood et al 2003, 
Mordechai et al 2004, Romeo et al 2004) or Raman spectroscopy (Mahadevan-Jansen et al 1998, 
Utzinger et al 2001, Ó Faoláin et al 2005) can be used for detecting spectral changes in 
malignant and pre-malignant cells.  Raman spectroscopy is, however, more suited to in vivo 
studies because of minimal interference from water.   
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Raman spectroscopy is an optical method based on inelastic light scattering.  The sample is 
illuminated by monochromatic laser light and interactions between the incident photons and 
molecules in the sample result in scattering of the light.  The exact energy required to excite a 
molecular vibration depends on the masses of the atoms involved in the vibration and the type of 
chemical bonds between these atoms and may be influenced by molecular structure, molecular 
interactions and the chemical microenvironment of the molecule.  Therefore, the positions, 
relative intensities and shapes of the bands in a Raman spectrum carry detailed information about 
the molecular composition of the sample (Socrates 2004). 
The aim of the present study was to gain an insight into the biochemical composition of cells and 
tissue by measuring Raman spectra from proteins, nucleic acids, lipids and carbohydrates and to 
show the diagnostic potential of Raman spectroscopy for cervical cancer and pre-cancer.   
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Materials and methods 
Sample preparation 
The samples examined were amino acids (all 20 amino acids), a dipeptide (arginine-lysine), 
proteins (albumin (bovine), β-galactosidase, and collagen (calf skin)), purines (adenine and 
guanine) and pyrimidines (cytosine and thymine), nucleic acid (salmon DNA), carbohydrates 
(glucose, glycogen), lipids (phosphatidylcholine and phosphatidylinositol) (Sigma-Aldrich, 
Dublin, Ireland).  Spectra were recorded in a polycrystalline form on a glass slide with no 
preparation required.   
Formalin fixed paraffin preserved (FFPP)  tissue samples were obtained from both the School of 
Biological Sciences, DIT, Kevin Street (tonsil, kidney and prostate) and the National Maternity 
Hospital, Holles St., Dublin (cervical tissue). Two parallel 10µm FFPP sections were cut from 
each block using a microtome, mounted on glass slides and dried. Samples (with the exception of 
cervical tissue) were dewaxed in-house in DIT prior to investigation by immersion in baths of 
Xylene (BDH), Ethanol Absolut (Merck) and Industrial Methylated Spirits 95% (Lennox) and 
air-dried.  Cervical tissue was dewaxed using the same procedure outlined above, but xylene was 
substituted with hexane, due to the improved level of dewaxing (Ó Faoláin et al. 2005).  One 
section from each sample (the reference section) was stained with Haematoxylin and Eosin and 
the other kept unstained for spectroscopic examination. 
 
FFPP cervical tissue sections were characterised by consultant pathologist Dr. P. Kelehan, 
National Maternity Hospital, Holles St., Dublin, and the samples consisted of 20 normal and 20 
invasive carcinoma sections from 40 individuals. Of the 20 carcinoma samples, 10 samples were 
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identified as having various grades of cervical intraepithelial neoplasia (CIN), which were also 
marked for examination.  
 
Spectroscopy 
The Instruments S.A. Labram Raman spectroscopic confocal microscope was used, with an 
Argon Ion laser operating at an excitation wavelength of 514.5nm. A x50 objective lens was 
used. The laser power at the sample was measured and found to be 6.5±0.05mW, focused to a 
spot size of ≈2µm at the tissue surface. A 30 second accumulation time was used for the 
crystalline samples.  Raman spectra of the various tissues were accumulated for 150 seconds.  A 
total of 10 spectra were recorded from different spots on each sample. 
Selected spectra were baseline corrected, dark current subtracted and were smoothed using a 10 
point moving average.  Where multiple spectra are displayed, spectra have been offset to 
facilitate clarity. 
 
Data Analysis 
All spectra (unfiltered) were subjected to spurious peak (“cosmic ray”) removal and baseline 
correction using a common baseline, in Labspec (v. 4.02 Jobin Yvon), before being exported in 
ASCII format to Microsoft Excel. Spectra were normalised to the spectral maximum, from 0 to 
1. Basic matrix manipulations and data reduction was carried out in Microsoft Excel Professional 
2003 (v. 11.0), before being exported into Minitab to perform Principal Component Analysis 
(PCA) and Linear Discriminant Analysis (LDA).  Minitab Release 14.1 Statistical Software 
Analysis Programme was used to produce PCA scores and LDA plots, as well as to carry out 
leave-one-out cross validation. 
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Results and Discussion 
 
Biochemical Analysis 
Amino acids, peptides and proteins 
All 20 common amino acids were examined using Raman spectroscopy and found to display 
characteristic spectral features. Figure 1a shows the chemical structure and the Raman spectrum 
of alanine and phenylalanine. The Raman spectra show many narrow bands, as would be 
expected due to the relatively simple structure of the amino acids. Each of the Raman peaks 
corresponds to a vibrational energy associated with the bonds within the sample.  The most 
distinctive peak in the spectrum of phenylalanine is the peak at 1004 cm-1 which can be attributed 
to the carbon-carbon stretching mode within the phenyl ring.  The fingerprint region of the 
spectrum (≈ 500 - 1700 cm-1) contains the majority of information and above 1700 cm-1 the 
spectrum contains mainly CH, CH2 and CH3 stretching modes around the 3000 cm-1 region (table 
1).  The spectra illustrate the ability of Raman spectroscopy to distinguish these molecules with 
their own distinctive signature spectrum.  
Raman spectra of the amino acids, arginine (Arg) and lysine (Lys) were compared to the Raman 
spectrum of the dipeptide Arg-Lys (figure 1b). The spectrum of the dipeptide clearly derives 
from a combination of the two amino acids (indicated by the arrows) and interestingly contains a 
new peak at 1665 cm-1. This is the Amide I band mainly due to C=O stretching modes of the 
peptide bond formed between arginine and lysine (table 1). 
Three different proteins, a serum protein, an enzyme and a structural protein, were examined; 
albumin, β-galactosidase and collagen (figure 1c). Compared to the amino acids and peptides, it 
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is clear that the proteins display a more detailed Raman signature, a function of their structure 
and crystalline form. 
Purines, pyrimidines and nucleic acids 
Figure 2a displays the Raman spectra of the purines and pyrimidines present in DNA, as well as 
a spectrum of DNA. Again contributions from the constituent molecules are present in the 
spectrum of DNA, but as seen with the protein spectra the peaks broaden as the molecular 
complexity increases.  
Carbohydrates  
Figure 2b shows the Raman spectra of carbohydrates; glucose and glycogen. Glucose displays 
many narrow vibrational modes, similar to the spectra of single amino acids, due to its relatively 
simple structure. The spectrum of glycogen on the other hand, shows broader spectroscopic 
features, as a result of its more complex polysaccharide structure.  
Lipids 
Raman spectra of phosphatidylcholine and phosphatidylinositol are shown in figure 2c.   The two 
phospholipids, which exist mainly in the extracellular membrane, can be clearly differentiated by 
presence of the peak seen at 714 cm-1, which can be attributed to the C-N vibrational mode in the 
membrane phospholipid head (Stone et al 2002) present in phosphatidylcholine but absent in 
phosphatidylinositol. 
Tissue 
Raman spectroscopy has been clearly shown to identify and discriminate between molecular 
components of cells and tissue. A number of different tissue types were examined and some of 
the generalised assignments common to different tissue types are shown in figure 3.  Raman 
bands found in these samples include the amide I band, resulting mainly from C=O stretching 
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vibrations of proteins, CH2 bending and CH2 deformation of lipids and carbohydrates, Amide III 
vibrations of proteins and CC stretching of carbohydrates. 
 
Diagnostic applications 
Cervical cancer 
Figure 4 shows the different cell types seen in normal cervical tissue in an unstained FFPP tissue 
section together with the Raman spectra recorded from basal cells, epithelial cells and connective 
tissue. Spectra were recorded from a single sample and each spectrum represents a different spot 
within the sample. The spectra of the three different cell types do have a degree of similarity as 
seen previously for different tissue types (figure 3). However, there are also many spectral 
features differentiating the different cell types. The spectra of basal cells show strong bands at 
724, 779 and 1578 cm-1 which are characteristic of nucleic acids. The same contributions were 
observed in the spectrum of DNA (figure 2a). The morphology of basal cells consists of a single 
line of tightly packed cells, with large nuclei in relation to the compacted surrounding cytoplasm. 
In addition, these cells are constantly dividing, providing cells to the parabasal layer. For both of 
these reasons a high concentration of DNA would be expected in the basal cells. Spectra of 
epithelial cells have characteristic glycogen bands at 482, 849, 938, 1082 and 1336 cm-1 as 
observed in the spectrum of glycogen in figure 2b. Collagen contributions can be clearly seen in 
the spectra of connective tissue at 850, 940 and 1245 cm-1 as seen in the spectrum of collagen in 
figure 1c. 
 
Figure 5a compares the Raman spectra collected from normal epithelial cells and invasive 
carcinoma from a selection of different patients. Glycogen contributions are clearly visible in the 
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spectra from the normal epithelial tissue. The most obvious bands arise at 482 cm-1, 849 cm-1 and 
938 cm-1 and are due to glycogen skeletal deformation, CCH aromatic deformation and CCH 
deformation respectively. However there are also other glycogen contributions not as apparent, 
including a CC stretching band at 1082 and CH3CH2 wagging at 1336 cm-1.  These glycogen 
bands (482, 849 and 938 cm-1) are absent in the spectra from invasive carcinoma, as well as a 
reduction in the intensity of the CC stretching mode (1082 cm-1). Glycogen, a polysaccharide, is 
the principal storage form of glucose.  Cervical cells are unusual among other epithelial cells in 
that they accumulate large amounts of glycogen during the maturation process (Chiriboga et al 
1998). Glycogen is known to be linked with cellular maturation and disappears with the loss of 
differentiation during neoplasia. The spectra of invasive carcinoma also show characteristic 
nucleic acid bands. These include prominent bands at 724, 779 and 1578 cm-1, but also at 829, 
852, 1002, 1098, 1240 cm-1. Distinct bands were also seen at 1366 cm-1, a shoulder at 1484 cm-1 
and a band at 1578 cm-1. An increase in the intensity of the Amide I band (1655cm-1) was 
observed in the spectra of carcinoma samples compared to the normal tissue samples.  The 
increased nucleic acid and protein bands are a result of the increased proliferation of these 
tumour cells. 
To investigate if pre-malignant changes could be highlighted using Raman spectroscopy, 10 
areas of neoplasia (CIN) from 10 different patients were marked by a pathologist and a selection 
of the resulting Raman spectra are shown in Figure 5b. A number of the spectral features 
identified in the invasive carcinoma samples were also observed in the CIN samples such as the 
nucleic acid bands at 724, 779, 852, 1366 and 1578 cm-1.  This indicates that early biochemical 
changes can be identified using Raman spectroscopy.  
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Principal component analysis was used to reduce the number of parameters needed to represent 
the variance in the spectral data set.  The principal components were then used to generate a 
linear discriminant model. PCA is a chemometric technique that can resolve a complete spectral 
data set into a few principal components and can thus identify and isolate important trends within 
the data set (Jackson 1991).  LDA applies a linear discriminant function that maximises the 
variance in the data between groups and minimises the variance between members of the same 
group (Otto 1999).  All three tissue classes were successfully discriminated as shown in figure 6.  
The classification model was tested using a leave one out cross validation in which all but one 
spectrum was used to build the model. This model was then used to predict the remaining 
spectrum. This was repeated for all 498 spectra and the results are shown in table 2. Of 498 
tissue spectra, 492 were correctly classified as normal, invasive carcinoma or CIN. The cross 
validation mis-classified 6 spectra, 2 of which were normal samples assigned as invasive 
carcinoma. The other 4 were either invasive carcinoma or CIN mis-classified as either CIN or 
invasive carcinoma respectively. Importantly, no abnormal samples were classified as normal.  
Based on the cross validation results, sensitivity and specificity values were calculated as 99.5% 
and 100% respectively for normal tissue, 99% and 99.2% respectively for CIN and 98.5% and 
99% respectively for invasive carcinoma.  It is possible that these values may be slightly over 
optimistic because of the LDA method used with leave one out cross validation. However, 
similar methods have been used previously to classify bladder and prostate cancer (Crow et al 
2005), breast cancer (Haka et al 2002) and basal cell carcinoma (Nijssen et al 2002).    Ideally, 
the use of an unknown test set would provide a more robust analysis of the sensitivity and 
specificity of the technique and this is planned for future work.   
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In conclusion, the results show the ability of Raman spectroscopy to classify cervical cancer and 
pre-cancer with high sensitivity and specificity. These classifications are based on biochemical 
changes known to accompany cervical cancer such as loss of differentiation and increased 
proliferation.  Such an automated technique measuring biochemical changes with improved 
diagnostic capability could allow faster, more effective patient management and inevitably 
would increase survival rates.  Raman spectroscopy offers enormous potential as a ‘next 
generation’ technology to assist pathologists and cytologists with cervical cancer screening and 
diagnosis.  
 
 
 
Acknowledgements 
 
The authors would like to express sincere thanks to all the staff in the Histology Department in 
the NMH Holles St. for all their generous co-operation.  The Focas Institute is funded under the 
Programme for Research in Third Level Institutions (PRTLI) administered by the Higher 
Education Authority (HEA). 
 
References 
Bolger N. , Heffron C., Regan I., Sweeney M., Kinsella S., McKeown M., Creighton G., Russell 
J., O'Leary J., 2006.  Implementation and evaluation of a new automated interactive image 
analysis system   Acta Cytol. 50(5), 483-91  
 
Carlson K., Pavlova I., Collier T., Descour M., Follen M., Richards-Kortum R., 2005. Confocal 
microscopy: Imaging cervical precancerous lesions.  Gynecologic Oncology, 99 (3) S84-88 
 13 
 
Chang S.K., Pavlova I., Marin N., Follen M., Richards-Kortum R., 2005.  Fluorescence 
spectroscopy as a diagnostic tool for detecting cervical pre-cancer.  Gynecologic Oncology, 99 
(3) S61-63 
 
Chiriboga L., Xie P., Yee H., Vigorita V., Zarou D., Zakim D., Diem M., 1998. Infrared 
spectroscopy of human tissue. I. Differentiation and maturation of epithelial cells in the human 
cervix. Biospectroscopy 4(1):47-53 
 
Crow P., Molckovsky A., Stone N., Uff J., Wilson B., WongKeeSong L.M., 2005.  Assessment 
of fiberoptic near-infrared raman spectroscopy for diagnosis of bladder and prostate cancer.  
Urology. 65(6), 1126-30. 
 
Escobar P.F., Belinson J.L., White A., Shakhova N.M., Feldchtein F.I., Kareta M.V., Gladkova 
N.D., 2004.  Diagnostic efficacy of optical coherence tomography in the management of 
preinvasive and invasive cancer of uterine cervix and vulva.  Int J Gynecol Cancer. 14(3), 470-4 
 
Gurjar R.S., Backman V., Perelman L.T., Georgakoudi I., Badizadegan K., Itzkan I., Dasari 
R.R., Feld M.S., 2001. Imaging human epithelial properties with polarized light-scattering 
spectroscopy, Nat Med. 7(11), 1245-8 
 
 14 
Haka A.S., Shafer-Peltier K.E., Fitzmaurice M., Crowe J., Dasari R.R., Feld M.S., 2002. 
Identifying microcalcifications in benign and malignant breast lesions by probing differences in 
their chemical composition using Raman spectroscopy.  Cancer Res. 62, 5375-5380 
 
Jackson J.E., 1991.  A User’s Guide to Principal Components. New York, Wiley. 
 
Koliopoulos G., Arbyn M., Martin-Hirsch P., Kyrgiou M., Prendiville W., Paraskevaidis E., 
2006. Diagnostic accuracy of human papillomavirus testing in primary cervcal screening: A 
review and meta-analysis of non-randomised studies.  Gynecologic Oncology, 
doi:10.1016/j.ygyno.2006.08.053 
 
Mahadevan-Jansen A., Ramanujam N., Malpica A., Thomsen S., Utzinger U., Richards-Kortum 
R., 1998. Near-Infrared Raman Spectroscopy for In Vitro Detection of Cervical Precancers. 
Photochemistry and Photobiology, 68(1), 123-132. 
 
Mordechai S., Sahu R.K., Hammody Z., Mark S., Kantarovich K., Guterman H., Podshyvalov 
A., Goldstein J., Argov S., 2004. Possible common biomarkers from FTIR microspectroscopy of 
cervical cancer and melanoma. Journal of Microscopy-Oxford, 215, 86-91. 
 
Nanda K., McCrory D.C., Myers E.R., Bastian L.A., Hasselblad V., Hickey J.D. Matchar D.B. 
2000.  Accuracy of the Papanicolaou test in screening for and follow up of cervical cytologic 
abnormalities: a systematic review.  Ann Intern Med, 132, (10), 810-819 
 
 15 
Nijssen A., Bakker Schut T.C., Heule F., Caspers P.J., Hayes D.P., Neumann M.H., Puppels 
G.J., 2002. Discriminating basal cell carcinoma from its surrounding tissue by Raman 
spectroscopy. J Invest Dermatol. 119, 64-9. 
 
Ó Faoláin E., Hunter M.B., Byrne J.M., Kelehan P., Byrne H.J., Lyng F.M., 2005. The potential 
of vibrational spectroscopy in the early detection of cervical cancer: an exciting emerging field. 
Proc. SPIE, Vol. 5826, 25-36. 
 
Ó Faoláin E., Hunter M.B., Byrne J.M., Kelehan P., Lambkin H.A., Byrne H.J., Lyng F.M.,  
2005. Raman spectroscopic evaluation of efficacy of current paraffin wax section dewaxing 
agents.  J. Histochem. Cytochem., 53, 121-131. 
 
Otto M., 1999. Chemometrics: Statistics and Computer Applications in Analytical Chemistry. 
New York, Wiley. 
 
Parkin D.M., Bray F., Ferlay J. and Pisani P., 2005. Global Cancer Statistics 2002, CA Cancer J 
Clin; 55:74-108 
 
Romeo M., Matthaus C., Miljkovic M., Diem M., 2004. Infrared microspectroscopy of 
individual human cervical cancer (HeLa) cells. Biopolymers, 74 (1-2), 168-171.  
 
 
 
 16 
Socrates G., 2004 “Infrared and Raman Characteristic Group Frequencies : Tables and Charts - 3 
edition” John Wiley & Sons. 
 
Stone N., Kendall C., Shepard N., Crow P., Barr H., 2002. Near-infrared Raman spectroscopy 
for the classification of epithelial and pre-cancers and cancer. Journal of Raman Spectroscopy, 
(33), 564-573. 
 
Utzinger U., Mahadevan-Jansen A., Hinzelman D., Follen M., Richards-Kortum R., 2001. Near 
Infrared Raman Spectroscopy for In Vivo Detection of Cervical Precancers. Applied 
Spectroscopy, 55 (8), 955. 
 
Willis B.H., Barton P., Pearmain P., Bryan S., Hyde C., 2005.  Cervical screening programmes: 
can automation help? Evidence from systematic reviews, an economic analysis and a simulation 
modelling exercise applied to the UK. Health Technol Assess, 9 (13), 1-207 
 
Wood B.R., Chiriboga L., Yee H., Quinn M.A., McNaughton D., Diem M., 2003. Fourier 
transform infrared (FTIR) spectral mapping of the cervical transformation zone and dysplastic 
squamous epithelium. Gynecologic Oncology, 93 (1), 59-68  
 
 
Zuluaga AF, Follen M, Boiko I, Malpica A, Richards-Kortum R., 2005. Optical coherence 
tomography: a pilot study of a new imaging technique for noninvasive examination of cervical 
tissue Am J Obstet Gynecol. 193(1), 83-88 
 17 
Legends 
Figure 1 Raman spectra of (a) alanine (A) and phenylalanine (B), (b) arginine (Arg) (A), 
lysine (Lys) (B) and dipeptide Arg-Lys (C) and (c) three proteins in ascending 
chain length; albumin (A), β-galactosidase (B) and collagen (C). Assignments of 
the main Raman vibrational modes are detailed in table 1. 
Figure 2 Raman spectra of a) cytosine (A), thymine (B) (pyrimidines), adenine (C), 
guanine (D) (purines) and DNA (E), b) carbohydrates, glucose (A), glycogen (B) 
and (c) phospholipids, phosphatidylinositol (A) and phosphatidylcholine (B).  
Raman peak assignments are detailed in table 1.  
Figure 3 Raman spectral features of various tissues, A) Tonsil B) Kidney and C) Prostate, 
with generalised assignments, where ν =  stretch and δ = deformation. 
Figure 4 (a) Photomicrograph of unstained tissue section, with different cell types 
identified and (b) Raman spectra recorded from basal cells (A), epithelial cells (B) 
and connective tissue (C) in cervical tissue sections. The main spectral features 
associated with each cell type are highlighted. 
Figure 5 Raman spectra of a) normal cervical epithelial cells (A) and invasive carcinoma 
cells (B) and (b) Raman spectra of CIN tissue. Assignments of the main Raman 
vibrational modes are detailed in table 1. 
Figure 6 Linear discriminant analysis of the principal components of the first derivative, 
normalised, 10 point averaged spectra, over the entire spectral range, C = CIN, N 
= normal and T = invasive carcinoma 
 
 
Table 1 Peak position and assignments of main Raman vibrational modes  
Peak Position  
(cm-1) Assignment 
622 C-C twisting  
724 CH2 deformation 
746 CH2 rocking 
754 Symmetric ring breathing  
779 Ring vibration 
832 CCH deformation aliphatic  
853 CCH deformation aromatic  
873 CC stretch  
922 C-C stretching  
1004 CC aromatic ring breathing 
1034 C-C stretching 
1065 C-N stretch 
1096 C-C chain stretching 
1098 CC stretch 
1102 CC stretch  
1124 CC skeletal stretch trans 
1214 CC stretch backbone carbon phenyl ring 
1236 CN stretch, NH bending Amide III band  
1240 CN stretch, NH bending Amide III band  
1314 CH deformation 
1337 CH2 deformation 
1335 CH2 deformation  
1366 CH2 bending 
1440 CH2 scissoring 
1484 CH2 deformation  
1548 NH deformation; CN stretch Amide II band  
1578 C=C olefinic stretch 
1585 C=C stretching 
1602 CO stretching 
1660 - 1665 C=O stretch Amide I α-helix 
2930 CH2 stretching (2930 cm-1)  
2932 CH3 symmetric stretch (2932 cm-1) 
 
 
Table 1
Table 2 Summary of cross-validation classification results and sensitivity and 
specificity values 
 
 Diagnosis (Histopathology)  
Predicted  (Raman) Normal CIN Invasive carcinoma 
Normal 198 0 0 
CIN 0 99 3 
Invasive carcinoma 2 1 195 
    
Total 200 100 198 
Number correct 198 99 195 
Proportion 0.990 0.990 0.985 
    
Sensitivity 99.5% 99.0% 98.5% 
Specificity 100% 99.2% 99.0% 
 
Table 2
(a)
(b)
(c)
Figure 1
(a)
(b)
(c)
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
